Navigation Links
Myriant Selected as a 2013 Red Herring Top 100 Global Company
Date:12/2/2013

Quincy, MA (PRWEB) December 02, 2013

Myriant Corporation, a global renewable chemicals company, today announced that Red Herring has named it a Top 100 Global award recipient, in recognition of the leading private companies from North America, Europe, and Asia, celebrating these startups’ innovations and technologies across their respective industries.

Red Herring’s Top 100 Global list has become a mark of distinction for identifying promising new companies and entrepreneurs. Red Herring editors were among the first to recognize that companies such as Facebook, Twitter, Google, Yahoo, Skype, Salesforce.com, YouTube, and eBay would change the way we live and work.

"Choosing the companies with the strongest potential was by no means a small feat," said Alex Vieux, publisher and CEO of Red Herring. "After rigorous contemplation and discussion, we narrowed our list down from hundreds of candidates from across the globe to the Top 100 Winners. We believe Myriant embodies the vision, drive and innovation that define a successful entrepreneurial venture. Myriant should be proud of its accomplishment, as the competition was the strongest it has ever been."

Red Herring’s editorial staff evaluated the companies on both quantitative and qualitative criteria, such as financial performance, technology innovation, management quality, strategy, and market penetration. This assessment of potential is complemented by a review of the track records and standing of startups relative to their peers, allowing Red Herring to see past the "buzz" and make the list a valuable instrument of discovery and advocacy for the most promising new business models from around the world.

About Myriant Corporation

Myriant is a global leader innovating and commercializing bio-based chemical intermediates with a focus on bio-succinic acid, bio-butanediol and bio-acrylic acid. Myriant is currently commercializing its bio-succinic acid and derivatives platform from two operating chemical plants: The first is Myriant’s flagship plant in Lake Providence, LA; the other, a commercial validation facility located in Leuna, Germany, which is operated by Myriant’s global partner, ThyssenKrupp Uhde. Myriant is a 2013 Red Herring Top 100 Company in North America. More information can be found at http://www.myriant.com.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11375844.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Myriant to Participate in U.S. DOE Biomass 2013 Conference
2. Piedmont Chemical Launches 100 Percent Renewable Polyester Polyols Leveraging Renewable Chemicals from DuPont Tate & Lyle Bio Products and Myriant Corporation
3. Verified Clinical Trials Selected to Prevent Dual Enrollment in Clinical Trials, Will Add Over 800 Additional Sites for a New Phase 3 North American Clinical Trial
4. BioStorage Technologies Selected to Provide Technical Consulting to Chinese National Genebank
5. Alpha Technics Selected to Design Sensor for Joint FDA and University of Maryland Scientific Study
6. Proove CEO and Vice Chairman of the Howard County Board of Education, Brian Meshkin, Selected as one of Howard County's Finest Under 39 by the Cystic Fibrosis Foundation
7. Emergent Technologies Selected to Serve 50 of the World’s Most Innovative Companies
8. Rocky Mountain Biologicals CEO Selected to Participate in the 2013 Montana Economic Development Conference in Butte
9. Mytrus Electronic Informed Consent System Selected for 2013 Product Leadership Award in Clinical Trials
10. Freeslate’s Biologics Formulation System Selected by Sanofi Pasteur to Improve Efficiency of Formulation Development
11. 2013 NASA Advanced Technology Phase I Concepts Selected For Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... Newly created 4Sight Medical Solutions ... the healthcare market. The company's primary focus is on new product introductions, to ... that are necessary to help companies efficiently bring their products to market. , ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... and BANGALORE, India , April ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... today announced a global partnership that will provide ... to use mobile banking and payment services.      ... a key innovation area for financial services, but it also ...
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
Breaking Biology News(10 mins):